Tivic Health Systems Regains Compliance with Nasdaq Listing Rules
FREMONT, Calif. – Tivic Health Systems, Inc. (TIVC), a leading therapeutics company, recently announced that it has regained compliance with the minimum bid requirements of Nasdaq Listing Rule 5550(a)(2). This news comes after a period of non-compliance with the rule, which requires a minimum bid price of $1.00 for continued listing on the Nasdaq Capital Market.
About Tivic Health Systems, Inc.
Tivic Health is a diversified therapeutics company focused on developing innovative medical devices for various conditions. The company’s product portfolio includes the ClearUp™ Sinus Pain Relief System, a non-invasive, handheld device for the treatment of sinus pain and pressure, and the g�mio™ Transcranial Magnetic Stimulation (TMS) System, a non-invasive treatment for major depressive disorder.
Impact on Tivic Health
The confirmation from Nasdaq that Tivic Health has regained compliance with the minimum bid requirements is a positive development for the company. Regaining compliance means that TIVC’s common stock will continue to be listed and traded on the Nasdaq Capital Market. This stability can help to improve investor confidence and potentially lead to increased interest in the company and its products.
Impact on the World
The news of Tivic Health’s regained compliance with Nasdaq listing rules may not have a significant impact on the world as a whole. However, it is a positive development for investors and stakeholders in the company. Additionally, the continued listing and trading of TIVC on the Nasdaq Capital Market may help to attract new investors and potentially lead to further innovation and development in the field of therapeutics.
Conclusion
Tivic Health Systems, Inc.’s recent confirmation of compliance with Nasdaq Listing Rule 5550(a)(2) is a positive development for the company and its investors. Regaining compliance means that TIVC’s common stock will continue to be listed and traded on the Nasdaq Capital Market, potentially leading to increased investor confidence and interest in the company. While the impact on the world may not be significant, the continued innovation and development in the therapeutics field can help to improve the lives of many individuals.
- Tivic Health Systems, Inc. has regained compliance with Nasdaq Listing Rule 5550(a)(2)
- Common stock will continue to be listed and traded on the Nasdaq Capital Market
- Positive development for the company and its investors
- Potential for increased investor confidence and interest
- Continued innovation and development in the therapeutics field
